Return to search

BillionToOne snaps up $125m Series C

BillionToOne, Inc., a next-generation molecular diagnostics company, has raised $125 million in Series C funding.

BillionToOne, Inc., a next-generation molecular diagnostics company, has raised $125 million in Series C funding. Adams Street Partners and Hummingbird Ventures led the round.

Source: Press Release